Michael Ronald Clark

Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis

Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions

Recombinant Human HPA-1A Antibodies for Treatment of Fetomaternal Alloimmune Thrombocytopenia (FMAIT): Proof of Principle in An in Vivo Murine Model and Human Volunteer Studies

Production of immunoglobulins which binds heterologous fcr with modified affinity

alloimmune thrombocytopenia: proof of principle in human volunteers Recombinant HPA-1a antibody therapy for treatment of fetomaternal

Binding molecules with biased recognition

Molécules de liaison présentant une reconnaissance biaisée

Human IgG isotypes and activating Fc gamma receptors in the interaction of Salmonella enterica serov

Expression of human Fc gamma RIIIa as a GPI-linked molecule on CHO cells to enable measurement of hu

Developing recombinant HPA-1a-specific antibodies with abrogated Fc gamma receptor binding for the t